DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award
The FY24 ALSRP Clinical Outcomes and Biomarkers Award aims to support the development and validation of clinical outcomes and biomarkers to enhance clinical trials for Amyotrophic Lateral Sclerosis (ALS). This includes projects focused on specific therapies, classes of therapeutics, or ALS subtypes like certain genetic mutations. Use of well-documented clinical resources is encouraged, includi…
The FY24 ALSRP Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in Amyotrophic Lateral Sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific …
Funding Source
Awards & funding
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers